Silva Pharmaceuticals Limited (DSE: SILVAPHL)

Silva Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 11, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Market Capitalization	1,897	2,948	3,290	2,689	2,498	2,990
Market Cap Growth	-28.24%	-10.37%	22.34%	7.65%	-16.46%	-
Enterprise Value	1,766	2,813	3,132	2,480	2,196	2,677
Last Close Price	13.90	21.50	23.66	18.81	17.00	19.65
PE Ratio	-	88.73	31.58	21.43	19.54	18.71
PS Ratio	3.10	4.11	4.22	3.36	3.27	4.08
PB Ratio	0.82	1.26	1.41	1.18	1.14	1.40
P/FCF Ratio	162.21	-176.51	-195.83	32.71	-118.19	-195.07
P/OCF Ratio	-126.96	42.06	20.45	16.87	16.58	15.74
EV/Sales Ratio	2.89	3.92	4.02	3.10	2.88	3.65
EV/EBITDA Ratio	49.48	26.22	17.96	11.96	10.51	13.71
EV/EBIT Ratio	-79.29	62.81	28.02	17.45	15.65	18.74
EV/FCF Ratio	150.95	-168.39	-186.43	30.16	-103.89	-174.63
Debt / Equity Ratio	0.02	0.03	0.04	0.02	0.02	-
Debt / EBITDA Ratio	1.31	0.56	0.55	0.20	0.21	-
Debt / FCF Ratio	4.00	-3.70	-5.90	0.52	-2.16	-
Asset Turnover	0.24	0.28	0.31	0.33	0.32	0.34
Inventory Turnover	0.92	1.00	1.04	1.07	1.11	1.12
Quick Ratio	5.69	5.11	3.76	6.13	3.15	6.17
Current Ratio	13.23	11.61	7.70	12.15	6.82	11.82
Return on Equity (ROE)	-1.33%	1.42%	4.45%	5.36%	5.49%	7.46%
Return on Assets (ROA)	-0.62%	1.11%	2.80%	3.62%	3.69%	4.15%
Return on Capital (ROIC)	-0.65%	1.16%	2.95%	3.90%	4.01%	4.53%
Earnings Yield	-1.63%	1.12%	3.11%	4.46%	4.76%	4.79%
FCF Yield	0.62%	-0.57%	-0.51%	3.06%	-0.85%	-0.51%
Dividend Yield	0.72%	0.47%	1.27%	2.66%	2.94%	2.91%
Payout Ratio	0.00%	75.66%	46.70%	39.46%	44.52%	-
Buyback Yield / Dilution	-	-	-	-	-30.00%
Total Shareholder Return	0.72%	0.47%	1.27%	2.66%	2.94%	-27.09%

Source: S&P Capital IQ. Standard template. Financial Sources.